Zalutumumab in Non-curable Patients With SCCHN

AKH Wien, Vienna

Universitätsklinik für Innere Medizin III, Salzburg

Medizinische Universität Graz, Graz

Istituto Nazionale Tumori, Milan

Istituto Europea di Oncologia, Milan

Azienda Ospedaliera Valtellina e Valchiavenna, Sondrio

Medizinische Universitätsklinik Lübeck, Lübeck

Rambam Medial Center, Haifa

Moffitt Cancer Center, Tampa

Universitätsklinikum Essen, Essen

Ft. Wayne Medical Oncology/Hematology, Inc, Fort Wayne

Henry Ford Health Systems, Detroit

Rabin Medical Center, Petah Tikva

Sheba Medical Center, Ramat Gan

Klinikum der Johann Wolfgang Goethe Universität, Frankfurt am Main

University Of Chicago Medical Center, Chicago

Sourasky Medical Center, Tel Aviv

Universitätsklinikum Heidelberg, Heidelberg

Baylor University Medical Center, Dallas

Uniklinik Freiburg, Freiburg im Breisgau

Narodny onkologicky ustav, Bratislava

Mountain States Tumor Institute, Boise

Soroka Medical Center, Beersheba

Shaare-Zedek Medical Center, Jerusalem

Loma Linda University Cancer Institute, Loma Linda

Oregon Health and Science University, Portland

Südharz-Krankenhaus Nordhausen gGmbH, Nordhausen

University of Alabama at Birmingham, Birmingham

Instituto Clinico Oncologico del Sur ICOS, Temuco

Hospital Carlos Van Buren de Valparaiso, Valparaíso

Instituto Oncologico, Viña del Mar

Centro de Investigaciones Oncologicas Clinica CIO San Diego S.A, Bogotá

Hospital Pablo Tobon Uribe, Medellín

Oncomedica S.A., Montería

Oncólogos del Occidente S.A., Pereira

Hospital Goyeneche, Arequipa

Hospital Nacional Carlos Alberto Seguin Escobedo, Arequipa

Hospital Nacional Almanzor Aguinaga Asenjo, Lambayeque

Hospital Central FAP, Lima

Hospital Nacional Guillermo Almenara Irigoyen, Lima

Facultni Nemocnice Hradec Kralove, Hradec Králové

Nemocnice Jihlava, Jihlava

Veseobecna Fakultni Nemocnice, Prague

Facultni Nemocnice Na Bulovce, Prague

IPO Coimbra, Coimbra

IPO Lisboa, Lisbon

IPO Porto, Porto

FN Trnava, Trnava